![Mark Parry Billings](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Parry Billings
Director/Board Member at Atopix Therapeutics Ltd.
Profile
Mark Parry Billings has been a Director at Atopix Therapeutics Ltd.
since 2016.
Mark Parry Billings active positions
Companies | Position | Start |
---|---|---|
Atopix Therapeutics Ltd.
![]() Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom. | Director/Board Member | 2016-11-16 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Atopix Therapeutics Ltd.
![]() Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Mark Parry Billings